Fowler Neal Franklin (CIK 1493692) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-04). Recent activity: Buy EBS (25,344 shares), Buy EBS (34,403 shares), Sell EBS (35,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-04 | Emergent BioSolutions Inc. (EBS) | Director | Buy | 25,344 | $0 |
| 2025-05-02 | Emergent BioSolutions Inc. (EBS) | Director | Buy | 34,403 | $0 |
| 2025-03-12 | Emergent BioSolutions Inc. (EBS) | Director | Sell | 35,000 | $204,050 |
Source: SEC Form 4 filings · as of 2026-05-04